Assessment of Beta Cell Mass by PET Scans With [11C] Dihydrotetrabenazine (DTBZ) in Longstanding Type 1 Diabetes.

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Paul Harris, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
ClinicalTrials.gov Identifier:
NCT00738907
First received: August 19, 2008
Last updated: September 23, 2014
Last verified: February 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2008
  Primary Completion Date: January 2008 (Final data collection date for primary outcome measure)